| Resistance (n = 21) | Remission (n = 28) | P |
Age Sex-ratio Hypertension Mean serum creatinine Renal insufficiency Anemia Lymphopenia C3 Hypocomplementemia CH50 Hypocomplementemia Anti-ENA Anti-dsDNA Mean proteinuria Nephrotic syndrome Microscopic hematuria Leukocyturia Delay between early symptomatology and start of treatment greater than 3 months | 35.4 ± 7.6 8H/13F 6 cas (28.57%) 3.3 ± 2.7 12 cas (57.14%) 19 cas (90.47%) 3 cas (14.28%) 1 cas (4.76%) 1 cas (4.76%) 8 cas (38.09%) 3 cas (14.28%) 3.7 ± 2.9 11 cas (52.38%) 6 cas (28.57%) 4 cas (19.04%) 19 cas (90.47%)
| 31.2 ± 8.4 3H/25F 6 cas (21.42%) 2.8 ± 2.2 7 cas (25%) 24 cas (85.71%) 4 cas (14.28%) 0 cas (0%) 0 cas (0%) 12 cas (42.85%) 5 cas (17.85%) 3.4 ± 2.6 16 cas (57.14%) 12 cas (42.85%) 11 cas (39.28%) 20 cas (71.42%)
| 0.564 0.711 0.765 0.851 0.355 0.212 0.012 0.965 0.965 0.519 0.003 0.185 0.011 0.015 0.786 0.655
|